The past few years have been full of unprecedented evolutions and challenges for the healthcare industry. To give a few examples, the COVID-19 pandemic has underscored the importance of healthcare innovations and collaborations, shifting perceptions to view them as essential, instead of just a cost. The patient’s voice has gained more prominence, influencing regulatory agencies, clinical trials and understanding of disease needs. And technology and Ai have started to accelerate access to innovative treatments.
Jean-Christophe Tellier
CEO UCB
“Our goal is for patients to benefit fully from new medicines, enabling them to live the life they desire, rather than one dictated by disease. To achieve this, we need a supportive environment – a robust infrastructure that includes science, clinicians, hospitals and key opinion leaders, as well as a strong dialogue between science and clinical practice.”
But what does this mean for the future of the healthcare industry?
According to Dr. Jean-Christophe Tellier, CEO at UCB, these evolutions and challenges should be turned into opportunities. In practice, this means that the industry needs to shift the public perception of healthcare from a cost to an investment that creates value and a healthier society. Stakeholders need to align in order to address unmet medical needs and ensure access to innovative solutions. And we need to build equity and sustainability into our healthcare ecosystem to fuel innovation across our regional disparities.
To achieve this, we need a unified, value-based healthcare system, cooperation among stakeholders and a shared ambition centred on patient value. In other words, a One Unified model of healthcare.
Learn more about the One Unified model
Read our interview with Dr. Jean-Christophe Tellier
Contact us
